title: Is it still clinically and economically viable in the UK to prescribe vacuum erection devices for patients with erectile dysfunction after radical prostatectomy?
authors.affiliation: Department of Urology, Hertfordshire and South Bedfordshire Robotic Cancer Centre, Lister Hospital, Stevenage, UK.
authors.forename: Nikhil
authors.initials: N
authors.lastname: Vasdev
authors.forename: Kimberley
authors.initials: K
authors.lastname: Hoyland
authors.forename: James M
authors.initials: JM
authors.lastname: Adshead
mesh_terms: D003362:Cost-Benefit Analysis; D007172:Erectile Dysfunction / Q000191:economics / Q000628:therapy*; D006801:Humans; D008297:Male; D058986:Phosphodiesterase 5 Inhibitors / Q000191:economics / Q000627:therapeutic use; D010818:Practice Patterns, Physicians' / Q000191:economics; D055656:Prescriptions / Q000191:economics*; D011468:Prostatectomy / Q000009:adverse effects* / Q000191:economics; D006113:United Kingdom; D014618:Vacuum
chemical_list: D058986:Phosphodiesterase 5 Inhibitors